BIOLINQ SHINE Trademark

Trademark Overview

On Wednesday, February 28, 2024, a trademark application was filed for BIOLINQ SHINE with the United States Patent and Trademark Office. The USPTO has given the BIOLINQ SHINE trademark a serial number of 98425578. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Saturday, March 21, 2026. This trademark is owned by Biolinq Incorporated. The BIOLINQ SHINE trademark is filed in the Medical Instrument Products category with the following description:

Wearable sensors used to measure biometric data for medical use; Glucose meters; wearable devices, namely, continuous sensors for monitoring metabolic indicators for medical purposes
biolinq shine

General Information

Serial Number98425578
Word MarkBIOLINQ SHINE
Filing DateWednesday, February 28, 2024
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateSaturday, March 21, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2024

Trademark Statements

Goods and ServicesWearable sensors used to measure biometric data for medical use; Glucose meters; wearable devices, namely, continuous sensors for monitoring metabolic indicators for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 28, 2024
Primary Code010
First Use Anywhere DateMonday, July 14, 2025
First Use In Commerce DateMonday, July 14, 2025

Trademark Owner History

Party NameBiolinq Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US
Party NameBiolinq Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
US

Trademark Events

Event DateEvent Description
Wednesday, February 28, 2024NEW APPLICATION ENTERED
Wednesday, July 10, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 13, 2024ASSIGNED TO EXAMINER
Friday, September 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 23, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 23, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 23, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 28, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 28, 2025SOU EXTENSION 1 FILED
Wednesday, May 28, 2025SOU EXTENSION 1 GRANTED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 17, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, September 17, 2025SOU EXTENSION 2 FILED
Wednesday, September 17, 2025SOU EXTENSION 2 GRANTED
Wednesday, September 17, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, September 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 21, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 17, 2025USE AMENDMENT FILED
Saturday, March 21, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

shine biolinq medical sensors wearable continuous monitoring metabolic purposes indicators namely glucose